
Singular Genomics Systems, Inc. is a medical - instruments & supplies company in the healthcare sector on NASDAQ, led by Andrew Spaventa, with a market cap of $50.8M. As of Q3 2025, 4% of shares are held by 1 institutional investors, with Virtue Capital Management, LLC as the largest holder at -.
Overview of institutional ownership in OMIC as of Q3 2025 with a market cap of $50.8M
Based on market cap of $50.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in OMIC as of Q3 2025
| Institution | Position Value |
|---|---|
V Virtue Capital Management, LLC RIA/Wealth | $1.9M 0.30% of portfolio |
Institutional buying and selling activity for OMIC in Q3 2025
| Institution | Net Bought |
|---|---|
V Virtue Capital Management, LLC RIA/Wealth | +$1.9M +353.2K shares |
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited OMIC in Q3 2025
| Institution | Position Value |
|---|---|
V Virtue Capital Management, LLC RIA/Wealth | $1.9M 353.2K shares |
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Institutions with the largest Call and Put options positions in OMIC as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with OMIC as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
V Virtue Capital Management, LLC RIA/Wealth | 0.30% $1.9M |
We use cookies for analytics. See our Privacy and Cookie Policy.